Skip to main content
Atrás
Watch Compare

NANOVIRICIDES, INC.

Calidad de datos: 83%
NNVC
NYSE Manufacturing Chemicals
$0.98
▼ $0.08 (-7.26%)
Cap. Mercado: 22.89 M
Precio
$1.06
Cap. Mercado
22.89 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Negative free cash flow of -7.43 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-91.18%
Below sector avg (-53.34%)
ROIC-72.69%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio4.43
Interest Coverage-168.54

Valoración

PE (TTM)
-2.75
Below sector avg (-1.47)
P/B Ratio2.07
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -2.8 -1.5
P/B 2.1 1.6
ROE % -91.2 -53.3
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Precio Objetivo de Analistas

2 analistas
Hold
Actual
$0.98
+561.2%
Objetivo
$6.50
$6.00
$6.50
$7.00
Pronóstico
P/E Futuro -2.81
EPS Futuro -$0.35
Ingresos Est. 0.0

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2027 -$0.35
-$0.35 – -$0.35
 0.0 1
FY2026 -$0.35
-$0.35 – -$0.35
 0.0 1

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q42025 -$0.08 -$0.11 -37.5%
Q32025 -$0.18 -$0.10 +44.4%
2026-Q2 -$0.08 -$0.12 -50.0%
2026-Q1 -$0.08 -$0.10 -25.0%

ETFs Holding This Stock

BRSIX BRSIX
0.05% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -8.32 M
ROE -91.18% ROA -80.66%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -7.43 M
ROIC -72.69% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4.43
Interest Coverage -168.54 Asset Turnover N/A
Working Capital 4.10 M Tangible Book Value 10.76 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.75 Forward P/E N/A
P/B Ratio 2.07 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -32.46%
Market Cap 22.89 M Enterprise Value 17.74 M
Per Share
EPS (Diluted TTM) -0.49 Revenue / Share N/A
FCF / Share -0.34 OCF / Share -0.34
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 89.33%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -9.47 M -8.29 M -8.59 M -8.11 M -8.82 M
EPS (Diluted) -0.63 -0.70 -0.74 -0.70 —
Gross Profit — — — — —
Operating Income -9.59 M -8.52 M -8.94 M -8.11 M -8.74 M
EBITDA — — — — —
R&D Expenses 5.55 M 5.44 M 6.39 M 5.78 M 6.11 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 49,808.0 49,808.0 938.0 5,123.0 85,405.0
Income Tax — — — — 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8.82 M 12.82 M 16.90 M 23.49 M 30.26 M
Total Liabilities 1.30 M 1.36 M 2.03 M — —
Shareholders' Equity 7.52 M 11.46 M 14.87 M 23.08 M 29.91 M
Total Debt — — — — —
Cash & Equivalents 1.56 M 4.80 M 8.15 M 14.07 M 20.52 M
Current Assets 1.67 M 4.97 M 8.45 M 14.42 M 20.82 M
Current Liabilities 1.31 M 1.36 M 534,250.0 412,837.0 351,146.0